Vimarsana
Biggest News Aggregation in the World

Page 26 - Future Forest News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Future Forest. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Future Forest Today - Breaking & Trending Today

Hennepin EMS paramedics add new tool to save lives as opioid overdoses increase - Vimarsana News

Hennepin EMS paramedics add new tool to save lives as opioid overdoses increase

Hennepin EMS paramedics started carrying Suboxone on ambulances last week, becoming one of a handful of paramedic systems in the country that administer the medication.

Investigation continues into fire that destroyed popular gathering place on Minnesota's North Shore - Vimarsana News

Investigation continues into fire that destroyed popular gathering place on Minnesota's North Shore

Minnesota’s North Shore lost a major community gathering spot over the weekend when a fire destroyed a restaurant at Lutsen Mountains ski resort.

Tornadoes touch down in Northwestern Minnesota - Vimarsana News

Tornadoes touch down in Northwestern Minnesota

While storms across the state stayed relatively tame, some in Mahnomen saw more extreme weather. The area was the target of tornadoes with wind speeds were between 135 to 160 miles per hour with some damage to homes. The National Weather Service had survey teams out all weekend and plan to release more information. This is an MPR News morning update, hosted by Cathy Wurzer. Music by Gary Meister.

Tony Bouza — outspoken, contrarian cop who once ran Minneapolis police — dies at 94 - Vimarsana News

Tony Bouza — outspoken, contrarian cop who once ran Minneapolis police — dies at 94

Tony Bouza, the outspoken, reform-minded New York City cop hired to run the Minneapolis Police Department in the 1980s, has died at age 94.

An Alzheimer's drug is on the way, but getting it may still be tough. Here's why - Vimarsana News

An Alzheimer's drug is on the way, but getting it may still be tough. Here's why

The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.